Spexis to host business update conference call on October 9, 2023

Spexis AG / Key word(s): Statement Spexis to host business update conference call on October 9, 2023 06.10.2023 / 07:30 CET/CEST

 

Spexis to host business update conference call on October 9, 2023

 

Allschwil, Switzerland, October 6, 2023

 

Spexis AG (SIX: SPEX), a clinical-stage biopharmaceutical company focused on macrocycle therapeutics for rare diseases and oncology, announced today that it will host a business update conference call on October 9, 2023, at 8.30am EDT.

Jeffrey D. Wager, M.D. (CEO & Chairman) will provide strategic business and financial updates. To access the conference call please use the following details:

France: [phone]
Germany: [phone]
Italy: [phone]
Switzerland [phone]
United Kingdom [phone]
United States [phone]

International Toll Free [phone]

 

Event Title: Spexis AG – Business Update Conference Call
 

The conference call will also be available via webcast: https://event.choruscall.com/mediaframe/webcast.html?webcastid=6s6eCE7 ...

After the call, a replay of the webcast will be available via the above link.

 

About Spexis

Spexis (SIX: SPEX) is a clinical-stage biopharmaceutical company based in Allschwil, Switzerland, focused on macrocycle therapeutics for rare diseases and oncology. For further information please visit: www.spexisbio.com.

 

For further information please contact:

For Investors: 
 
Hernan Levett
Chief Financial Officer
Spexis AG.
[phone]
[e-mail]

Or

Stephen Jasper
Managing Director
Gilmartin Group
[e-mail]

 

For Media: 
 
Dr. Stephan Feldhaus
Feldhaus & Partner
[phone]
[e-mail]

 

 

---

End of Media Release

---

Language:	English
Company:	Spexis AG
	Hegenheimermattweg 125
	4123 Allschwil
	Switzerland
Phone:	[phone]
Fax:	[phone]
E-mail:	[e-mail]
Internet:	www.spexisbio.com
ISIN:	CH0106213793
Valor:	SPEX
Listed:	SIX Swiss Exchange
EQS News ID:	1742821

End of News	EQS News Service

1742821  06.10.2023 CET/CEST